Article info
PDFA difficult case
Erdheim-Chester disease: misdiagnosed as multiple sclerosis
- Correspondence to Dr Jason Yang, Medicine, The University of Queensland - Saint Lucia Campus, Saint Lucia, Queensland, Australia; drtwyang{at}gmail.com
Citation
Erdheim-Chester disease: misdiagnosed as multiple sclerosis
Publication history
- Accepted October 9, 2023
- First published November 6, 2023.
Online issue publication
March 27, 2024
Article Versions
- Previous version (19 March 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Novel paraneoplastic mechanism for cerebellar ataxia in Erdheim-Chester disease
- Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS
- Imaging in multiple sclerosis and related disorders
- Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement
- Hypothalamic lesions in multiple sclerosis
- Peritoneal or mesenteric tumours revealing histiocytosis
- Erdheim–Chester disease associated with a novel, complex BRAF p.Thr599_Val600delinsArgGlu mutation
- Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinoma
- Efficacy of infliximab in the treatment of Erdheim-Chester disease
- Erdheim-Chester disease: a rare non-Langerhans histiocytosis